Price T Rowe Associates Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.21 - $0.53 $2,079 - $5,247	9,900 Added 21.33%	56,310 $14,000
Q1 2022 May 16, 2022	BUY	$0.32 - $0.67 $5,312 - $11,122	16,600 Added 55.69%	46,410 $25,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $840 - $1,554	1,400 Added 4.93%	29,810 $18,000
Q2 2021 Aug 16, 2021	BUY	$1.39 - $2.21 $23,586 - $37,501	16,969 Added 148.32%	28,410 $52,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $746 - $2,010	588 Added 5.42%	11,441 $23,000
Q4 2020 Feb 16, 2021	BUY	$0.94 - $1.89 $10,201 - $20,512	10,853 New	10,853 $14,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.